We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+1.53%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$64.8B
AUM Growth
-$1.23B
Cap. Flow
+$395M
Cap. Flow %
0.61%
Top 10 Hldgs %
28.4%
Holding
1,116
New
212
Increased
277
Reduced
389
Closed
160

Top Sells

Rank Stock Value
1
RNAM
Avidity Biosciences
RNAM
+$190M
2
RPRX icon
Royalty Pharma
RPRX
+$187M
3
DOV icon
Dover
DOV
+$178M
4
BA icon
Boeing
BA
+$168M
5
DVN icon
Devon Energy
DVN
+$155M

Sector Composition

Rank Sector Weight
1 Technology 27.24%
2 Healthcare 15.45%
3 Financials 12.46%
4 Industrials 9.23%
5 Communication Services 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROIV icon
26
Roivant Sciences
ROIV
$25.2B
$354M 0.55%
12,794,097
+2,116,203
+20% +$54.4M
NFLX icon
27
Netflix
NFLX
$292B
$349M 0.54%
3,632,430
-403,400
-10% -$35.5M
MRK icon
28
Merck
MRK
$324B
$323M 0.5%
2,687,439
-411
-0% -$47.5K
ABBV icon
29
AbbVie
ABBV
$458B
$320M 0.49%
1,470,271
-38,444
-3% -$8.53M
HD icon
30
Home Depot
HD
$332B
$314M 0.48%
953,856
-107,800
-10% -$39.3M
BAC icon
31
Bank of America
BAC
$435B
$312M 0.48%
6,399,373
-105,900
-2% -$5.46M
CSCO icon
32
Cisco
CSCO
$450B
$301M 0.46%
3,884,521
-23,200
-0.6% -$1.82M
PLTR icon
33
Palantir
PLTR
$295B
$299M 0.46%
2,046,400
-18,200
-0.9% -$2.78M
GE icon
34
GE Aerospace
GE
$367B
$294M 0.45%
1,034,763
+148,400
+17% +$46.6M
OVV icon
35
Ovintiv
OVV
$17.5B
$291M 0.45%
4,907,109
-555,000
-10% -$26.8M
CSX icon
36
CSX Corp
CSX
$98.6B
$291M 0.45%
7,085,533
+3,252,825
+85% +$127M
BSX icon
37
Boston Scientific
BSX
$65.8B
$291M 0.45%
4,633,237
+2,550,877
+122% +$204M
KO icon
38
Coca-Cola
KO
$354B
$289M 0.45%
3,802,182
+377,100
+11% +$28.5M
CTRA
39
DELISTED
Coterra Energy
CTRA
$289M 0.45%
8,219,512
+7,122,100
+649% +$214M
ORCL icon
40
Oracle
ORCL
$331B
$282M 0.44%
1,919,116
+49,000
+3% +$7.96M
CAT icon
41
Caterpillar
CAT
$409B
$274M 0.42%
386,804
+2,426
+0.6% +$1.68M
RTX icon
42
RTX Corp
RTX
$287B
$272M 0.42%
1,412,457
+269,588
+24% +$53.6M
AMD icon
43
Advanced Micro Devices
AMD
$851B
$270M 0.42%
1,325,594
-59,200
-4% -$12.6M
TMO icon
44
Thermo Fisher Scientific
TMO
$211B
$268M 0.41%
545,832
-18,336
-3% -$9.95M
TNGX icon
45
Tango Therapeutics
TNGX
$4.34B
$268M 0.41%
12,809,485
+2,201,561
+21% +$30.6M
PRAX icon
46
Praxis Precision Medicines
PRAX
$9.07B
$263M 0.41%
815,739
-149,574
-15% -$46.3M
UNH icon
47
UnitedHealth
UNH
$382B
$259M 0.4%
956,506
+92,154
+11% +$27.4M
LRCX icon
48
Lam Research
LRCX
$382B
$247M 0.38%
1,158,120
-133,500
-10% -$29.8M
NSC icon
49
Norfolk Southern
NSC
$78.8B
$245M 0.38%
854,036
+55,943
+7% +$16.6M
VNOM icon
50
Viper Energy
VNOM
$8.81B
$235M 0.36%
5,004,690
-706,849
-12% -$30.3M

Similar funds

Adage Capital Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Adage Capital Partners held 1,116 positions worth $64.8B, down 1.9% from $66.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Adage Capital Partners's Q1 2026 filing shows 212 new, 277 increased, 389 reduced and 160 closed positions. Its largest new stake was Takeda Pharmaceutical: 6,424,984 shares worth $119M. The largest sale was Avidity Biosciences, an estimated $190M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q1 2026 buy was Takeda Pharmaceutical: 6,424,984 shares worth $119M.
  • Adage Capital Partners added most to Revolution Medicines in Q1 2026, an estimated $330M increase.
  • Adage Capital Partners's biggest Q1 2026 reduction was Royalty Pharma, cutting an estimated $187M.
  • Adage Capital Partners fully exited Avidity Biosciences in Q1 2026, selling an estimated $190M.
  • Adage Capital Partners's ten largest holdings make up 28% of its $64.8B portfolio in Q1 2026.
  • Adage Capital Partners opened 212 new positions and closed 160 in Q1 2026.
  • Adage Capital Partners's portfolio value fell 1.9% quarter-over-quarter to $64.8B.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.